FloraWorks
A specialized biotech enterprise discovering rare and novel cannabinoids for commercial and therapeutic applications.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $2.3m | Series A | |
| Total Funding | 000k | ||
Related Content
FloraWorks is a specialized supplier of hemp-derived cannabinoids, focusing on high-quality CBN isolate with over 98% Cannabinol content. The company serves both consumer and enterprise markets, providing critical first-mover advantages in the cannabinoid industry. FloraWorks partners with leading brands in cannabinoid edibles and topicals, helping them bypass costly R&D efforts to develop new product lines that meet stringent quality and consistency standards. Operating in a highly competitive market, FloraWorks leverages its extensive industry expertise to navigate complex development, manufacturing, and regulatory challenges. The business model revolves around wholesale distribution of CBN isolate and collaborative partnerships, ensuring products are properly formulated and positioned for success. Revenue is generated through bulk sales and strategic alliances with brands seeking to innovate in the cannabinoid space.
Keywords: hemp-derived cannabinoids, CBN isolate, wholesale, consumer applications, enterprise solutions, cannabinoid edibles, topicals, R&D, regulatory expertise, strategic partnerships.